Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × Oesophagogastric Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1076 Carcinoma, Non-Small-Cell Lung 670 Neoplasms 651 Colorectal Neoplasms 635 Stomach Neoplasms 503 Carcinoma, Hepatocellular 502 Prostatic Neoplasms 418 Lung Neoplasms 385 Pancreatic Neoplasms 353 Rectal Neoplasms 277 Recurrence 271 Neoplasm Metastasis 263 Leukemia, Myeloid, Acute 257 Multiple Myeloma 238 Colonic Neoplasms 234 Ovarian Neoplasms 231 Lymphoma 228 Uterine Cervical Neoplasms 224 Esophageal Neoplasms 223 Melanoma 211 Head and Neck Neoplasms 209 Precursor Cell Lymphoblastic Leukemia-Lymphoma 168 Brain Neoplasms 167 Lymphoma, Large B-Cell, Diffuse 165 Nasopharyngeal Carcinoma 153 Leukemia 152 Lymphoma, Non-Hodgkin 144 Glioblastoma 144 Lymphoma, Follicular 135 Liver Neoplasms 134

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡